Currently, there is no literature to our knowledge that demonstrates FOXO3 is required for the caspase-3-mediated cleavage of PARP1 and caspase-3 proteins and for auranofin-induced apoptotic signaling in cancer cells. This evidence concerns the gene PARP1 and cancer.